1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow dacomitinib: new trials by email Literature Review of dacomitinib trials Research Report on dacomitinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib. Dacomitinib, Osimertinib - EGFR Gene Mutation, Lung Cancer | Early Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 17 | 2018-11-21 | 2025-05-15 |
Lung Neoplasms (1)
Memorial Sloan Kettering Cancer Center (1)
United States (1)
Helen Yu, MD (1)